等待开盘 09-19 09:30:00 美东时间
-0.324
-1.13%
Tinlarebant has been granted Breakthrough Therapy, Fast Track, and Rare Pediatric Disease Designations in the U.S.; Orphan Drug Designation in the U.S., Europe, and Japan; and Pioneer Drug Designation in Japan for
09-12 20:07
Draganfly Inc. announced the expansion of its U.S. manufacturing capabilities, including AS9100- and ISO9001-certified facilities, to meet rising demand for U.S.-made drones. This expansion aligns with recent U.S. government initiatives to boost domestic drone production and reduce reliance on foreign supply chains. CEO Cameron Chell emphasized the company's commitment to creating a more agile and secure drone ecosystem while improving delivery e...
08-28 11:15
Draganfly Inc. announced a shareholder update call on August 11, 2025, at 5:30 PM EST. CEO Cameron Chell will discuss key milestones, and CFO Paul Sun will present Q2 2025 performance highlights. The formal financial results will be released after market close on August 11. Shareholders can register for the call and submit questions in advance via email.
08-08 11:15
Draganfly Inc. and Infinity Communications announced the successful sale of multiple Draganfly Heavy Lift Drones to a Fortune 50 telecommunications company for UAV-based emergency response and communication network capabilities. The drones, equipped with remote sensors and communications payloads, will be used in disaster recovery operations to transport supplies and restore communications in inaccessible areas. The partnership highlights the eff...
07-30 11:15
SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a ...
07-23 20:00
Draganfly Inc. announced the sale of Commander 3XL UAV systems to a global defense contractor for military surveillance. The modular payload architecture, extended endurance, and AI-enabled mission control make the Commander 3XL ideal for military-grade surveillance, supporting perimeter security, early warning, and real-time situational awareness. This sale is a significant milestone for Draganfly in expanding its defense sector presence. The te...
07-22 11:15
Draganfly Inc. completed a registered direct offering of 4,672,895 units at US$5.35 per unit, raising approximately US$25.0 million. Each unit includes one common share and one warrant exercisable at CA$7.3579, expiring in five years. Maxim Group LLC acted as the sole placement agent. Proceeds will be used for general corporate purposes, product development, and growth initiatives. The offering was conducted in the U.S. under SEC regulations, wit...
07-21 20:19
Draganfly Inc.'s Commander3 XL UAV platform was selected by a major U.S. Department of Defense branch for advanced reconnaissance and operational capabilities. Known for its versatility, the platform will support intelligence, surveillance, and reconnaissance (ISR) missions. Cameron Chell, CEO, highlighted the platform's reliability and adaptability, aligning with the DoD's focus on multi-mission systems. Draganfly, a leader in drone solutions, h...
07-16 11:15